Reliability of small amounts of cancer in prostate biopsies to reveal pathologic grade

Urology

Volumn 67, Issue 6, 2006, Pages 1229-1234

  King, Christopher R ^a   McNeal, John E ^a   Gill, Harcharan ^a   Brooks, James D ^a   Srinivas, Sandy ^a   Presti Jr , Joseph C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC VALUE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RELIABILITY; TUMOR BIOPSY; TUMOR VOLUME;

ADULT; AGED; BIOPSY, NEEDLE; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS;

EID: 33744510037     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2005.12.031     Document Type: Article

References (15)

1. Bostwick D.G. Gleason grading of prostate needle biopsies. correlation with grade in 316 matched prostatectomies. Am J Surg Pathol 18 (1994) 796-803
2. Steinberg D.M., Sauvageot B.S., Piantadosi S., et al. Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings. Am J Surg Pathol 21 (1997) 566-576
3. King C.R., McNeal J.E., Gill H., et al. Extended prostate biopsy scheme improves reliability of Gleason grading. implications for radiotherapy patients. Int J Radiat Oncol Biol Phys 59 (2004) 386-391
4. Gleason D.F. Histologic grading of prostate cancer. a perspective. Hum Pathol 23 (1992) 273-279
5. Roach III M., DeSilvio M., Lawton C., et al. Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression. Radiation Therapy Oncology Group 9413. J Clin Oncol 21 (2003) 1904-1911
6. Pilepich M.V., Caplan R., Byhardt R.W., et al. Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy. report of RTOG 85-31. J Clin Oncol 15 (1997) 1013-1021
7. Bolla M., Gonsalez D., Warde P., et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 337 (1997) 295-300
8. Hanks G.E., Pajak T.F., Porter A., et al. Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate. the Radiation Therapy Oncology Group protocol 92-02. J Clin Oncol 21 (2003) 3972-3978
9. D'Amico A.V., Schultz D., Loffredo M., et al. Biochemical outcome following external beam radiation therapy with or without androgen suppression for clinically localized prostate cancer. JAMA 284 (2000) 1280-1283
10. Freedland S.J., Aronson W.J., Csathy G.S., et al. Comparison of percentage of total prostate needle biopsy tissue with cancer to percentage of cores with cancer for predicting PSA recurrence after radical prostatectomy. results from the SEARCH database. Urology 61 (2003) 742-747
11. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer. J Clin Oncol 18 (2000) 1164-1172
12. Grossklaus D.J., Coffey C.S., Shappell S.B., et al. Percent of cancer in the biopsy set predicts pathological findings after prostatectomy. J Urol 167 (2002) 2032-2035
13. Lewis Jr. J.S., Vollmer R.T., and Humphrey P.A. Carcinoma extent in prostate needle biopsy tissue in the prediction of whole gland tumor volume in a screening population. Am J Clin Pathol 118 (2002) 442-450
14. D'Amico A.V., Keshaviah A., Manola J., et al. Clinical utility of the percentage of positive prostate biopsies in predicting prostate cancer-specific and overall survival after radiotherapy for patients with localized prostate cancer. Int J Radiat Oncol Biol Phys 53 (2002) 581-587
15. Merrick G.S., Butler W.M., Galbreath R.W., et al. Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland. Int J Radiat Oncol Biol Phys 52 (2002) 664-673